NEWS
Conflicting Health Information Compromises Attention and Emotional Responses
The 24-hour news cycle and social media bombardment often resulting in conflicting messages about health issues might be making it harder than ever for people to make critical decisions, according to a Rutgers-led study. The study, published in Journal of Behavioral...
New NJACTS Publication
Please read Dr. Aleksunes' article in Drug Metabolism and Disposition titled, "BCRP/ABCG2 Transporter Regulates Accumulation of Cadmium in Kidney Cells: Role of the Q141K Variant in Modulating Nephrotoxicity." The heavy metal cadmium is a high-priority environmental...
Why people with mood disorders are now eligible for COVID vaccine boosters.
Millions of people in the United States with mental health conditions are newly eligible for COVID-19 vaccine booster shots. The Centers for Disease Control and Prevention has added mood disorders to its list of health conditions that put people at risk for severe...
At-Home COVID Tests Promise Fast Results Ahead Of Holiday Gatherings, But Are They Accurate? CBS2 Investigates.
ust in time for Thanksgiving gatherings, several kinds of rapid COVID tests you can take home are hitting the market. Some give results within minutes, and soon they will be able to test for both COVID and the flu. Looking to other countries, this could be the...
Triple Therapy Effective for Severe COPD Exacerbations.
Treatment with once-daily single-inhaler fluticasone furoate/umeclidinium/vilanterol (Trelegy Ellipta) triple therapy appears to be more efficacious in reducing severe exacerbations in patients with chronic obstructive pulmonary disease (COPD) than the standard...
Princeton’s innovation and entrepreneurship conference – LIVE ONLINE DEC. 1-2
Register today for Princeton’s annual innovation and entrepreneurship conference. Join fellow innovators to make connections and discover your own opportunities – through industry intersections, entrepreneurship, transformational research and Princeton's leadership of...
Could a cheap drug spell ‘game over’ for the pandemic?
Since COVID-19 reared its ugly head more than 18 months ago, public health experts have longed to bolster their pandemic toolbox with a pill that could easily treat coronavirus. They may finally have one. Fluvoxamine, an off-patent, widely available antidepressant,...
COVID-19 Will Likely Become an Endemic Disease—But When Will That Happen?
As the US prepares to enter into its third winter season dealing with COVID-19, an unanswered question—first asked back in the earliest days of the pandemic—remains: When will it be over? Unfortunately, the answer may be "never"—many experts no longer believe the...